Ranked #1
Sjögren's syndrome: what do we know so far?
Sjögren's syndrome: what do we know so far?
Professor Xavier Mariette (Head of Rheumatology at Université Paris-Sud, France) is an expert in Sjögren's syndrome. He ... Read more
25 Jan 2018
•
5mins
Ranked #2
Osteoarthritis or rheumatoid? The MDHAQ patient questionnaire role in routine rheumatology care
Osteoarthritis or rheumatoid? The MDHAQ patient questionnaire role in routine rheumatology care
Editor-in-Chief of RMD Open Bernard Combe is joined by Theodore Pincus, Rheumatologist at the Rush University, Chicago, ... Read more
13 Mar 2018
•
6mins
Ranked #3
Rheumatic immune-related adverse events of checkpoint therapy for cancer
Rheumatic immune-related adverse events of checkpoint therapy for cancer
Cassandra Calabrese (Cleveland Clinic Foundation, Ohio, USA) speaks with Editor-in-Chief of RMD Open Bernard Combe about... Read more
6 Dec 2017
•
5mins
Ranked #4
Branded drug or biosimilar? Reasons to adopt generics in rheumatology, by Professor Jonathan Kay
Branded drug or biosimilar? Reasons to adopt generics in rheumatology, by Professor Jonathan Kay
Professor Jonathan Kay (Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School and... Read more
6 Nov 2017
•
5mins
Ranked #5
Early diagnosis and treatment: the Rheumatic Diseases Portuguese Register
Early diagnosis and treatment: the Rheumatic Diseases Portuguese Register
Dr Joao Fonseca, head of the Rheumatology Department at the Lisbon Academic Medical Centre (Faculdade de Medicina da Uni... Read more
17 Jul 2017
•
5mins